Subclinical thyroid disease

British Medical Bulletin

Volumn 107, Issue 1, 2013, Pages 101-116

  Garg, Anukul ^a   Vanderpump, Mark P J ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Autoimmune thyroid disease; Screening; Subclinical hyperthyroidism; Subclinical hypothyroidism

Indexed keywords

AMIODARONE; CHORIONIC GONADOTROPIN; INTERFERON; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICROSOME ANTIBODY; RADIOACTIVE IODINE; THIONAMIDE DERIVATIVE; THYROID ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE BINDING GLOBULIN;

ADDISON DISEASE; ARTICLE; BONE DENSITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; ECHOCARDIOGRAPHY; EUTHYROID SICK SYNDROME; EXTERNAL BEAM RADIOTHERAPY; FRAGILITY FRACTURE; GLOBULIN BLOOD LEVEL; GRAVES DISEASE; HASHIMOTO DISEASE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART RATE; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; META ANALYSIS (TOPIC); MORBIDITY; NODULAR GOITER; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; SPINE FRACTURE; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; SUBCLINICAL THYROID DISEASE; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; THYROID HORMONE RESISTANCE; THYROID SCINTISCANNING; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROTROPIN SECRETING ADENOMA; ADVERSE OUTCOME; HIGH RISK PATIENT; INTERVENTION STUDY; PATIENT CARE;

EID: 84887983587     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldt024     Document Type: Article

References (86)

1. Woeber KA. Treatment of hypothyroidism. In: Braverman LE, Utiger RD (eds). Werner and Ingbar's the Thyroid, a Fundamental and Clinical Text, 9th edn. Philadelphia, USA: Lippincott Williams&Wilkins, 2005, 864-9.
2. Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull 2011;99: 39-51.
3. Tunbridge WMG, Evered DC, Hall R et al. The spectrum of thyroid disease in the community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7: 481-93.
4. Roberts CGP, Ladenson PW. Hypothyroidism. Lancet 2004;363: 793-803.
5. Biondi B, Cooper DC. Subclinical thyroid disease. Lancet 2012;379: 1142-54.
6. Association of Clinical Biochemistry, British Thyroid Association and British Thyroid Foundation (2006) UK Guidelines for the Use of Thyroid Function Tests: ACB and BTA, London. http://www.british-thyroid-association.org/info-for- patients/Docs/TFT-guideline-final-version-July-2006.pdf. (accessed 1 July 2013).
7. Surks MI, Hollowell JG. Age specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007;92: 4575-82.
8. Stagnaro-Green A, Abalovich M, Alexander E et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011;21: 1081-125.
9. Glinoer D, de Nayer P, Bourdoux P et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 1990;71: 276-87.
10. Yeo CP, Khoo DH, Eng PH et al. Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chonrionic gonadotrophin. Clin Endocrinol (Oxf) 2001;55: 391-8.
11. Goodwin TM, Montoro M, Mestman JH et al. The role of chorionic gonadotrophin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 1992;75: 1333-7.
12. Chopra IJ. Clinical review 86: euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 1997;82: 329-34.
13. Attia J, Margetts P, Guyatt G. Diagnosis of thyroid disease in hospitalized patients. A systematic review. Arch Intern Med 1999;159: 658-65.
14. Canaris GJ, Manowitz NR, Mayor G et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160: 526-34.
15. Abraham-Nordling M, Torring O, Lantz M et al. Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005. Eur J Endocrinol 2008;158: 823-7.
16. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87: 489-99.
17. Vanderpump MPJ. The epidemiology of thyroid diseases. In: Braverman LE, Utiger RD (eds). Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text, 9th edn. Philadelphia, USA: JB Lippincott-Raven, 2005, 398-496.
18. Schouten BJ, Brownlie BE, Frampton CM et al. Subclinical thyrotoxicosis in an outpatient population - predictors of outcome. Clin Endocrinol (Oxf) 2011;74: 257-61.
19. Vadiveloo T, Donnan PT, Cochrane L et al. The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 2011;96: 59-61.
20. Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007;116: 1725-35.
21. Tribulova N, Knezl V, Shainberg A et al. Thyroid hormones and cardiac arrhythmias. Vascul Pharmacol 2010;52: 102-12.
22. Biondi B, Palmieri EA, Fazio S et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000;85: 4701-5.
23. Sgarbi JA, Villaca F, Garbeline B et al. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism on clinical and heart abnormalities. J Clin Endocrinol Metab 2003;88: 1672-7.
24. Auer JA, Scheibner P, Mische T et al. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2001;142: 838-42.
25. Gammage MD, Parle JV, Holder RL et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007;167: 928-34.
26. Cappola AR, Fried LP, Arnold AM et al. Thyroid status, cardiovascular risk, and mortality in older adults. J Am Med Assoc 2006;295: 1033-41.
27. Sawin CT, Geller A, Wolf PA et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331: 1249-52.
28. Gussekloo J, van Exel E, de Craen AJ et al. Thyroid status, disability and cognitive function, and survival in old age. J Am Med Assoc 2004;292: 2591-9.
29. Iervasi G, Molinaro S, Landi P et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med 2007;167: 1526-32.
30. Sgarbi JA, Matsumura LK, Kasamatsu TS et al. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study. Eur J Endocrinol 2010;162: 569-77.
31. Walsh JP, Bremner AP, Bulsara MK et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 2005;165: 2467-72.
32. Boekholdt SM, Titan SM, Wiersinga WM et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf) 2010;72: 404-10.
33. de Jongh RT, Lips P, van Schoor NM et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol 2011;165: 545-54.
34. Collet TH, Gussekloo J, Bauer DC et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012;172: 799-809.
35. Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk - a meta-analysis. Thyroid 2003;13: 585-93.
36. Foldes J, Tarjan G, Szathmary M et al. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is the thyroid status a risk factor for osteoporosis? Clin Endocrinol (Oxf) 1993;39: 521-7.
37. Mudde AH, Houben AJ, Nieuwenhuijzen Kruseman AC. Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol (Oxf) 1994;41: 421-4.
38. Bauer DC, Ettinger B, Nevitt MCet al. For the Study of Osteoporotic Fractures Research Group. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2001;134: 561-8.
39. Lee JS, Buzkova P, Fink HA et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med 2010;170: 1876-83.
40. Roberts LM, Pattison H, Roalfe A et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med 2006;145: 573-81.
41. Grabe HJ, Volzke H, Ludemann J et al. Mental and physical complaints in thyroid disorders in the general population. Acta Psychiatr Scand 2005;112: 286-93.
42. Kalmijn S, Mehta KM, Pols HA et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 2000;53: 733-7.
43. Tan ZS, Beiser A, Vasan RS et al. Thyroid function and the risk of Alzheimer disease: the Framingham study. Arch Intern Med 2008;168: 1514-20.
44. Dobert N, Hamscho N, Menzel C et al. Subclinical hyperthyroidism in dementia and correlation of the metabolic index in FDG-PET. Acta Med Austriaca 2003;30: 130-3.
45. van Osch LA, Hogervorst E, Combrinck M et al. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology 2004;62: 1967-71.
46. Parle JV, Maisonneuve P, Sheppard MC et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001;358: 861-5.
47. Ochs N, Auer R, Bauer DC et al. Meta-analysis: subclinical thyroid dysfunction and the risk of coronary heart disease and mortality. Ann Intern Med 2008;148: 832-45.
48. Mitchell AL, Pearce SHS. How should we treat patients with low serum thyrotrophin concentrations? Clin Endocrinol 2010;72: 292-6.
49. Demers LM, Spencer CA, editors. Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. National Academy of Clinical Biochemistry, 2002. URL: http://www.nacb.org/monograph/ Thyroid-index.htm (accessed 1 July 2013).
50. Surks MI, Ortiz E, Daniels GH et al. Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management. J Am Med Assoc 2004;291: 228-38.
51. Meyerovitch J, Rotman-Pikielny P, SherfMet al. Serum thyrotrophin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med 2007;167: 1533-8.
52. Vanderpump MPJ, Tunbridge WMG, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 1995;43: 55-69.
53. McGrogan A, Seaman HE,Wright JW et al. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf) 2008;69: 687-96.
54. Flynn RV, MacDonald TM, Morris AD et al. The Thyroid Epidemiology, Audit and Research Study: thyroid dysfunction in the general population. J Clin Endocrinol Metab 2004;89: 3879-84.
55. Leese GP, Flynn RV, Jung RT et al. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit and Research Study (TEARS). Clin Endocrinol (Oxf) 2008;68: 311-6.
56. Biondi B. Cardiovascular effects of mild hypothyroidism. Thyroid 2007;17: 625-30.
57. Owen PJ, Sabit R, Lazarus JH. Thyroid disease and vascular function. Thyroid 2007;17: 519-24.
58. Taddei S, Caraccio N, Virdis A et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003;88: 3731-7.
59. Razvi S, Weaver JU, Vanderpump MP et al. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab 2010;95: 1734-40.
60. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003;88: 2438-44.
61. Meier C, Staub JJ, Roth CB et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001;86: 4860-6.
62. Danese MD, Ladenson PW, Meinert CL et al. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000;85: 2993-3001.
63. Muller B, Zulewski H, Huber P et al. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med 1995;333: 964-9.
64. Bakker SJ, ter Maaten JC, Popp-Snijders C et al. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab 2001;86: 1206-11.
65. Rodondi N, Newman AB, Vittinghoff E et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005;165: 2460-6.
66. Rodondi N, Bauer DC, Cappola AR et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health Study. J Am Coll Cardiol 2008;52: 1152-9.
67. McQuade C, Skugor M, Brennan DM et al. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid 2011;21: 837-43.
68. Rodondi N, den Elzen WPJ, Bauer DC et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. J Am Med Assoc 2010;304: 1365-74.
69. Razvi S, Shakoor A, Vanderpump MPJ et al. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a meta-analysis. J Clin Endocrinol Metab 2008;93: 2998-3007.
70. Atzmon G, Barzali N, Hollowell JG et al. Extreme longeivity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009;94: 1251-4.
71. Cooper DS, Halpern R, Wood LC et al. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med 1984;101: 18-24.
72. Nystrom E, Caidahl K, Fager G et al. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf) 1988;29: 63-7.
73. Jaeschke R, Guyatt G, Gerstein H et al. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996;11: 744-9.
74. Kong WM, Sheikh MH, Lumb PJ et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med 2002;112: 348-54.
75. Jorde R, Waterloo K, Storhaug H et al. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab 2006;91: 145-53.
76. Razvi S, Ingoe L, Keeka G et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 2007;92: 1715-23.
77. Parle J, Roberts L, Wilson S et al. A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid Study. J Clin Endocrinol Metab 2010;95: 3623-32.
78. Lindeman RD, Schade DS, LaRue A et al. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc 1999;47: 703-9.
79. Simonsick EM, Newman AB, Ferrucci L et al.,. Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med 2009;169: 2011-7.
80. van den Boogaard E, Vissenberg R, Land JA et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 2011;17: 605-19.
81. Teng W, Shan Z. Pregnancy and thyroid diseases in China. Thyroid 2011;21: 1053-5.
82. Li Y, Shan Z, Teng Wet al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol (Oxf) 2010;72: 825-9.
83. Haddow JE, Palomaki GE, Allan WC et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341: 549-55.
84. Yu X, Shan Z, Teng W et al. A prospective study on impact of subclinical hypothyroidism during pregnancy receiving levothyroxine treatment or not on neuropsychological development of the offspring. ITC 2010-1037. In: Presented at: 14th International Thyroid Conference, Paris, France, September 11-16, 2010.
85. Lazarus JH, Bestwick JP, Channon S et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012;366: 493-501.
86. Razvi S, Weaver JU, Butler TJ et al. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med 2012;172: 811-7.